Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome

Rajmohan Dharmaraj1, Pankaj Hari, Arvind Bagga

  • 1Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi 110029, India.

Insights

This study shows that combining human albumin with frusemide infusion significantly increases urine output in children with nephrotic syndrome. This combination therapy enhances diuresis and natriuresis compared to frusemide alone.

Area of Science:

  • Nephrology
  • Pediatrics
  • Pharmacology

Background:

  • Hypoalbuminemia in nephrotic syndrome can impair diuretic response.
  • The efficacy of combining loop diuretics with human albumin is debated.
  • Refractory edema is a common challenge in pediatric nephrotic syndrome.

Purpose of the Study:

  • To evaluate the efficacy of co-administering human albumin and frusemide infusion versus frusemide infusion alone in children with nephrotic syndrome.
  • To assess the impact on diuresis, natriuresis, and other relevant clinical parameters.

Main Methods:

  • A randomized cross-over trial involving 16 children with nephrotic syndrome and refractory edema.
  • Participants received either 20% human albumin and frusemide infusion (HA+FU) or frusemide infusion alone (FU) in a cross-over design.

Main Results:

  • The HA+FU group showed significantly higher median urine volume (3.27 ml/kg/hr) compared to the FU group (1.33 ml/kg/hr) (P=0.01).
  • Weight loss was significantly greater in the HA+FU group (5.2%) versus the FU group (0.8%) (P=0.006).
  • Osmoalr clearance was also significantly higher in the HA+FU group (1600 ml/day) compared to the FU group (880 ml/day) (P=0.01).

Conclusions:

  • Co-administration of albumin and frusemide infusions is more effective than frusemide infusion alone for inducing diuresis and natriuresis in nephrotic syndrome patients.
  • This combination therapy may be a valuable strategy for managing refractory edema in pediatric nephrotic syndrome.
  • Further research could explore optimal dosing and long-term outcomes.

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...